Plasminogen Activator Inhibitor Type 1 Interacts with 3 Subunit of Proteasome and Modulates Its Activity
Documents
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: Implications for oxidative stress and insolubility of newly synthesized proteins
Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and Carfilzomib
Proteasome-associated proteins: regulation of a proteolytic machine
Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells
Proteasome inhibitor PS-341 induces apoptosis in cisplatin-resistant squamous cell carcinoma cells by induction of Noxa
Harnessing Proteasome Dynamics and Allostery in Drug Design
Inhibition of the Ubiquitin—Proteasome Pathway Alters ...
Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells
The ubiquitin-proteasome system regulates focal adhesions ... - eLife
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Alternative UPS drug targets upstream the 26S proteasome
Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation
Inhibition of Proteasome Activity Strongly Affects Kiwifruit Pollen Germination. Involvement of the Ubiquitin/Proteasome Pathway as a Major Regulator
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
